ASX:DXS DEXUS (DXS) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About DEXUS Stock (ASX:DXS) 30 days 90 days 365 days Advanced Chart Get DEXUS alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume5.01 million shsAverage VolumeN/AMarket CapitalizationA$8.03 billionP/E Ratio16.80Dividend Yield5.39%Price TargetN/AConsensus RatingN/A Company Overview Dexus (ASX: DXS) is a leading Australasian fully integrated real asset group, managing a high-quality Australasian real estate and infrastructure portfolio valued at $61.0 billion (pro forma post final completion of the AMP Capital acquisition). We believe that the strength and quality of our relationships will always be central to our success and are deeply connected to our purpose: Unlock potential, create tomorrow. We directly and indirectly own $17.4 billion of office, industrial, healthcare, retail and infrastructure assets and investments. We manage a further $43.6 billion of investments in our funds management business (pro forma post final completion of the AMP Capital acquisition) which provides third party capital with exposure to quality sector specific and diversified real asset products. The funds within this business have a strong track record of delivering performance and benefit from Dexus's capabilities. The group's $17.4 billion real estate development pipeline provides the opportunity to grow both portfolios and enhance future returns. Our sustainability aspiration is to unlock the potential of real assets to create lasting positive impact and a more sustainable tomorrow, and is focused on the priorities of customer prosperity, climate action and enhancing communities. Dexus is supported by more than 34,000 investors from 25 countries. With four decades of expertise in property investment, funds management, asset management and development, we have a proven track record in capital and risk management and delivering returns for investors. Read More Receive DXS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DEXUS and its competitors with MarketBeat's FREE daily newsletter. Email Address DXS Stock News HeadlinesFuture Fund ditches Dexus as manager of its Melbourne Airport stakeJune 19, 2025 | afr.comCriterion: With declining rates, the marked-down REITs sector is starting to purrMay 23, 2025 | msn.comElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan. | Brownstone Research (Ad)Dexus wins Melbourne Airport reprieve, says co-investors overreactingMay 21, 2025 | afr.comInside the bitter battle for Melbourne AirportMay 18, 2025 | afr.comDexus shares drop as it denies breaching confidentiality termsMay 16, 2025 | msn.comDexus’s Melbourne Airport stake at risk as co-investors cry foulMay 15, 2025 | afr.comASX Market Open: Hopeful traders put Trump's tariffs tizz in rearview mirror | April 14, 2025April 14, 2025 | msn.comSee More Headlines DXS Stock Analysis - Frequently Asked Questions What other stocks do shareholders of DEXUS own? Based on aggregate information from My MarketBeat watchlists, some other companies that DEXUS investors own include Medibank Private (MPL), Accenture (ACN), AECOM (ACM), Accel Entertainment (ACEL), Abbott Laboratories (ABT), Abacus Property Group (ABP) and AbbVie (ABBV). Company Calendar Ex-Dividend for 8/28 Dividend6/26/2025Today7/03/2025Record date for 8/28 Dividend8/28/2025Dividend Payable8/28/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorReal Estate Industry REIT - Office Sub-IndustryN/A Current SymbolASX:DXS CIKN/A Webwww.dexus.com Phone+61-2-90171100FaxN/AEmployees1,079Year FoundedN/AProfitability EPS (Trailing Twelve Months)A($1.47) Trailing P/E Ratio16.80 Forward P/E RatioN/A P/E Growth3.87Net Income-A$1.58 billion Net Margins49.62% Pretax MarginN/A Return on Equity4.44% Return on Assets-0.80% Debt Debt-to-Equity Ratio49.23 Current Ratio0.95 Quick Ratio0.44 Sales & Book Value Annual SalesA$338.30 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow175.29 Book ValueA$9.45 per share Price / BookN/AMiscellaneous Outstanding Shares1,080,000,000Free FloatN/AMarket CapA$8.03 billion OptionableNot Optionable Beta0.81 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (ASX:DXS) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DEXUS Please log in to your account or sign up in order to add this asset to your watchlist. Share DEXUS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.